Economic grand rounds: the economics of the new medicare drug benefit: implications for people with mental illnesses.
Donohue
Julie M
JM
Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Crabtree Hall A613, Pittsburgh, Pennsylvania 15261, USA. jdonohue@pitt.edu
D000368:Aged; D003363:Cost Control; D017047:Cost Sharing / Q000191:economics / Q000331:legislation & jurisprudence; D016527:Drug Costs / Q000706:statistics & numerical data*; D016568:Drugs, Generic / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D019458:Insurance Coverage / Q000191:economics / Q000331:legislation & jurisprudence; D007356:Insurance, Pharmaceutical Services / Q000191:economics* / Q000331:legislation & jurisprudence*; D006278:Medicare / Q000191:economics* / Q000331:legislation & jurisprudence*; D001523:Mental Disorders / Q000188:drug therapy* / Q000191:economics; D010602:Pharmacopoeias as Topic; D011619:Psychotropic Drugs / Q000191:economics* / Q000627:therapeutic use; D014481:United States
D016568:Drugs, Generic; D011619:Psychotropic Drugs